Unwinding the helix: using genetics to treat childhood cancer
- OPACC
- Jul 23, 2012
- 1 min read
Pediatric leukemia is a cancer of the blood and bone marrow. There are about 3,000 new cases in the United States every year, typically in children between the ages of four and six. With treatment, about three-quarters of affected children are able to beat the disease. But for those with what’s known as “high risk” leukemia, the odds of survival are much worse.
Washington University pediatric oncologist Dr. Todd Druley has been trying to use genetics to understand why some leukemia is so hard to treat. He spoke with St. Louis Public Radio's Véronique LaCapra.
Recent Posts
See AllDuring cancer treatment, children can face hurdles to maintaining healthy eating. Chemotherapy has many side effects, including loss of...
Quality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
Comments